Concepedia

Quantitative technetium pyrophosphate and cardiovascular magnetic resonance in patients with suspected cardiac amyloidosis

Golnaz Roshankar, Geneva White, Sebastien Cadet, Nowell M. Fine, Denise Chan, James A. White, Víctor H. Jiménez‐Zepeda, Piotr J. Slomka, Robert J.H. Miller

Journal of Nuclear Cardiology · 2021 · 18 citations · 35 references

DOI

Concepts

References

35

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Jeffrey H. Schwartz, Balarama Gundapaneni, Perry Elliott et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

, , +13

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

Julian D. Gillmore, Rodney H. Falk, Giampaolo Merlini et al. · Circulation · 2016 · 2K citations · Full text

, , +14

Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99m Tc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy

Enrica Perugini, Pier Luigi Guidalotti, Fabrizio Salvi et al. · Journal of the American College of Cardiology · 2005 · 965 citations

, , +16

Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System

Martha Grogan, Christopher G. Scott, Robert A. Kyle et al. · Journal of the American College of Cardiology · 2016 · 736 citations

, , +17

2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials

Karen A. Hicks, James E. Tcheng, Biykem Bozkurt et al. · Circulation · 2014 · 704 citations

, , +10